Complete KPRX Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
KPRX Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 6 peer companies in Healthcare
P/E Ratio
$-178.00
-5827.3%
Peer Median: 62.3x
EV/EBITDA
$105.78
+3303.4%
Peer Median: 45.5x
P/S Ratio
$0.10
-96.9%
Peer Median: 14.9x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for KPRX's business model and current situation.
Multiple Comparison
| Multiple | KPRX Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.1x | 62.3x | 40.6x | -101.7% | Undervalued |
| EV/EBITDA | 0.8x | 45.5x | 23.1x | -98.2% | Undervalued |
| P/S Ratio | 473.0x | 14.9x | 8.2x | 3084.0% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 1.5x | |
| $0.01B | 19.0x | 0.7x | 473.0x | |
| $0.01B | 0.0x | 0.0x | 42.3x | |
| $727.98B | 62.3x | 45.5x | 14.9x |